Announcements Trials
Browse Landscape

Phase

Phase 2 9Phase 1 8Phase 3 2Phase 1/2 2Phase NA 1

Status

Completed 8

Sponsor Class

INDUSTRY 8OTHER 5NIH 2

Study Type

Interventional 8

Sponsor

Cancer Type

Tumor-Agnostic 4Genitourinary 2Gastrointestinal 2Plasma cell 1

Conditions

Neoplasms 5Kidney Neoplasms 2Multiple Myeloma 1Liver Neoplasms 1Colonic Neoplasms 1

Interventions

pembrolizumab 304Paclitaxel 206Carboplatin 200Gemcitabine 173Cisplatin 139Docetaxel 138Cyclophosphamide 136Nivolumab 129Bevacizumab 118Injections 111fludarabine 96atezolizumab 91Pemetrexed 90Dexamethasone 90Cetuximab 90Fluorouracil 84Irinotecan 77Rituximab 72Capecitabine 72venetoclax 71Azacitidine 70130-nm albumin-bound paclitaxel 67Leucovorin 65Fulvestrant 58Oxaliplatin 57durvalumab 56Trastuzumab 56Lenalidomide 55Ipilimumab 55Midazolam 54

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

8 trials
RecentStart dateEnrollment
Phase 1 × INDUSTRY × perifosine × Clear all
NCT01048580 2018-06-28

Study of Perifosine + Capecitabine for Colon Cancer Patients

AEterna Zentaris

Phase 1 Completed
10 enrolled
Gastrointestinal

Colonic Neoplasms

NCT01224730 2018-03-14

A Food Effect and QTc Study of Perifosine in Patients With Advanced Malignancies

AEterna Zentaris

Phase 1 Completed
24 enrolled
Tumor-Agnostic

Neoplasms

NCT00398814 2014-02-19

Phase I Study of Perifosine + Sorafenib for Patients With Advanced Cancers

AEterna Zentaris

Phase 1 Completed
30 enrolled
GastrointestinalGenitourinary

Kidney Neoplasms, Liver Neoplasms, Neoplasms

NCT00399152 2014-02-19

Perifosine + Sunitinib Malate for Patients With Advanced Cancers

AEterna Zentaris

Phase 1 Completed
15 enrolled
Genitourinary

Kidney Neoplasms

NCT00398697 2014-02-13

Phase I Perifosine and Gemcitabine Study

AEterna Zentaris

Phase 1 Completed
19 enrolled
Tumor-Agnostic

Neoplasms

NCT00399087 2014-02-13

Phase I Trial of Docetaxel With Perifosine

AEterna Zentaris

Phase 1 Completed
39 enrolled
Tumor-Agnostic

Neoplasms

NCT00399126 2014-02-13

Phase I Trial of Paclitaxel With Perifosine

AEterna Zentaris

Phase 1 Completed
24 enrolled
Tumor-Agnostic

Neoplasms

NCT00415064 2012-07-06

Phase I Study of Perifosine + Lenalidomide and Dexamethasone for Patients With Multiple Myeloma

AEterna Zentaris

Phase 1 Completed
32 enrolled
Plasma cell

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡